Infinion Biopharma has filed a DRHP with capital market regulatory body SEBI to go public. This initial public offering will include selling 45 lakh equity shares at a face value of Rs. 10 per share. Besides the public issue, Infinion Biopharma is also considering a pre-IPO placement of 7 lakh shares. Furthermore, Aryaman Financial Services …
By the closing date on 3 September 2021, Vijaya Diagnostic IPO was subscribed 4.54 times and received bids for 11,36,44,020 shares. The IPO’s issue size was Rs. 1,895 crores. This IPO comprises entirely of an offer for sale, as per its DRHP. Day 3 Subscription Status of Vijaya Diagnostic IPO Given below is Vijaya Diagnostic IPO …
At the end of the third day, Ami Organics’ IPO received a total subscription of 64.54 times, receiving 42,22,36,296 bids for its shares. The IPO issue size here is worth Rs. 569.64 crores. As per the DRHP, it includes fresh issue shares of up to Rs. 200 crores and an OFS of Rs. 369.64 crores. …
Investors could witness WAPCOS’s initial public offer by the end of March. As per reports, the Department of Investment and Public Asset Management or DIPAM had floated tenders in February. The said tenders were to engage a registrar and an advertising firm to sell a nearly 25% stake in WAPCOS via a public offer. WAPOS …
Indian e-commerce giant Snapdeal is considering going public with an issue of about $400 million. Backed by SoftBank Group Corporation, the online shopping company is in discussion with its advisors regarding this public offer. According to sources close to the company, they are targeting a Dalal Street debut by next year with an estimated valuation …
On 2 September 2021, the Government of India was looking for bids from legal advisors for the second time regarding LIC IPO, which is believed to be the largest ever public offering in India. This decision was passed in light of the low interest during its first attempt. So, what’s cooking here, and how will …
Ami Organics closed its IPO for public subscription on 3 September 2021. The Rs. 570 crores IPO comprised Rs. 200 crores new issue and an OFS worth Rs. 370 crores. Collectively, the shares were subscribed a total of 64.54 times. Subsequently, this specialty chemical company is set to announce its basis of allotment on 8 …
Veeda Clinical Research – the Ahmedabad-based medical analysis organisation, is on the verge of lifting Rs. 500 – 700 crores through an IPO. As per sources, the company is planning to submit the DRHP to the Securities and Exchange Board of India (SEBI). Following this news, the firm declined any comments. But why should investors …
The mega IPO of the country’s biggest state-backed insurance company, Life Insurance Corporation of India, is planned for FY2020-21. However, one of its largest trade unions, All India LIC Employees’ Federation, suggests that this initial public offering can lead to job losses. In addition, the Union expects it to impact LIC’s social infrastructure spending plans. …
Taking a cue from the boom of tech space in this country, Byjus’s, one of India’s leading education portals, plans to accelerate its public offering. The prominent reason behind it seems to be the intention of making the most of the prospects of India’s tech space. That said, Byju’s intends to accelerate its public offering …
